SAN FRANCISCO, CA, SkySQL has secured $6.6 million in new funding to redefine cloud database management with groundbreaking AI and serverless capabilities. Read More
SAN JOSE, CA, Ayar Labs, the leader in optical interconnect solutions for large-scale AI workloads, announced it has secured $155 million in financing led by Advent Global Opportunities and Light Street Capital. Read More
LITTLE ROCK, AR, The Computer Works (TCW), a leading provider of fiber and fixed wireless internet services based in Arkansas, announced the completion of a significant growth capital investment. Read More
MINNEAPOLIS, MN, Players Health, the leading provider of athlete safety and sports insurance solutions, announced the successful closing of its $60 million Series C funding round. The round was led by Bluestone Equity Partners. Read More
WATERTOWN, MA, Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the close of a $15 million Series A funding round. Read More
NEW YORK, NY, VIOLETTE_FR, the award-winning multi-category clean beauty brand renowned for its artistically imbued, high-performance cosmetics, proudly announces the completion of a Series B funding round. Read More
OAKLAND, CA, Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science using AI, announced a $22.5 million Series A funding round led by Coatue. Read More
CAMBRIDGE, MA, Kaymbu, a leading classroom documentation and family engagement platform for early childhood education, has landed a growth funding package from Decathlon Capital Partners. Read More
AUSTIN, TX, RapidCanvas announced a $16M funding round for its AI agents that automate up to 75% of complex tasks traditionally performed by data scientists and engineers. Read More
MESA, AZ, Koantek, a leading Databricks technology partner and trusted advisor, announced that it has secured funding from Databricks Ventures. Read More
SANTA CRUZ, CA, Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the successful closing of an oversubscribed $110 million Series C. Read More
WOODLAND HILLS, CA, Angitia Biopharmaceuticals, a clinical-stage biotechnology company, announced the closing of a $120 million Series C financing round. Read More
